Gen-Probe, Inc.

10210 Genetic Center Drive,
San Diego, California 92121
United States,
(858) 410-8000
www.gen-probe.com

Gen-Probe, Inc., is a provider in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility.

M&A Summary

Buy vs Sell

Year ≤ '05 '06 '07 '08 '09 '10 T
Buy (0.4/yr) # - - - - 1 1 2
vol $143M $53M $196M
Sell (0.0/yr) # - - - - - - 0
  2

Top M&A Advisors

Financial Deals
Sign-up to View
1
Legal Deals
Sign-up to View
2
Sign-up to View
1

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Tepnel Life Sciences PLC
$143M (2009-01-30)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

Gen-Probe was acquired by Hologic on August 01, 2012.

Gen-Probe has acquired 2 companies of its own. A total of 2 acquisitions came from private equity firms.

Gen-Probe’s largest acquisition to date was in 2009, when it acquired Tepnel Life Sciences for $143M. Gen-Probe has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (50%) and test/measurement equipment (50%).

When analyzing the medical products sector as a whole, according to Mergr, in the last 3 years, there are 329 medical products companies that have made at least 1 acquisition, 17 have acquired at least 5 companies, and 4 have acquired more than 10 companies. The most prolific strategic medical products acquirer over the past 3 years is Medtronic, with 12 acquisitions. The most prolific private equity acquirer in the medical products sector over the past 3 years is SHS GmbH with 7 platform acquisitions.

Join Mergr and gain access to Gen-Probe’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.